146 related articles for article (PubMed ID: 22117884)
1. Systemic therapy with conventional and novel immunomodulatory agents for ocular inflammatory disease.
Durrani K; Zakka FR; Ahmed M; Memon M; Siddique SS; Foster CS
Surv Ophthalmol; 2011; 56(6):474-510. PubMed ID: 22117884
[TBL] [Abstract][Full Text] [Related]
2. Treatment of ocular inflammatory disorders with daclizumab.
Papaliodis GN; Chu D; Foster CS
Ophthalmology; 2003 Apr; 110(4):786-9. PubMed ID: 12689903
[TBL] [Abstract][Full Text] [Related]
3. Treatment of ocular inflammation in children.
Thadani SM; Foster CS
Paediatr Drugs; 2004; 6(5):289-301. PubMed ID: 15449968
[TBL] [Abstract][Full Text] [Related]
4. Scleritis therapy.
Sainz de la Maza M; Molina N; Gonzalez-Gonzalez LA; Doctor PP; Tauber J; Foster CS
Ophthalmology; 2012 Jan; 119(1):51-8. PubMed ID: 22015381
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory therapy for the treatment of ocular inflammatory disease: evidence-based medicine recommendations for use.
Kim EC; Foster CS
Int Ophthalmol Clin; 2006; 46(2):141-64. PubMed ID: 16770160
[No Abstract] [Full Text] [Related]
6. Malignancy risk in patients with inflammatory eye disease treated with systemic immunosuppressive therapy: a tertiary referral cohort study.
Yates WB; Vajdic CM; Na R; McCluskey PJ; Wakefield D
Ophthalmology; 2015 Feb; 122(2):265-73. PubMed ID: 25312044
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive therapy and cancer risk in ocular inflammation patients: fresh evidence and more questions.
Khachatryan N; Kempen JH
Ophthalmology; 2015 Feb; 122(2):219-21. PubMed ID: 25618424
[No Abstract] [Full Text] [Related]
8. [New methods of therapy for ocular inflammatory autoimmune diseases].
Kubicka-Trzaska A; Undas A
Klin Oczna; 2003; 105(6):428-32. PubMed ID: 15049272
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis.
Murphy CC; Ayliffe WH; Booth A; Makanjuola D; Andrews PA; Jayne D
Ophthalmology; 2004 Feb; 111(2):352-6. PubMed ID: 15019389
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate for ocular inflammatory diseases.
Gangaputra S; Newcomb CW; Liesegang TL; Kaçmaz RO; Jabs DA; Levy-Clarke GA; Nussenblatt RB; Rosenbaum JT; Suhler EB; Thorne JE; Foster CS; Kempen JH;
Ophthalmology; 2009 Nov; 116(11):2188-98.e1. PubMed ID: 19748676
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory therapy for ocular inflammatory disease: a basic manual and review of the literature.
Okada AA
Ocul Immunol Inflamm; 2005; 13(5):335-51. PubMed ID: 16419419
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of mucous membrane pemphigoid with etanercept in 3 patients.
Canizares MJ; Smith DI; Conners MS; Maverick KJ; Heffernan MP
Arch Dermatol; 2006 Nov; 142(11):1457-61. PubMed ID: 17116836
[TBL] [Abstract][Full Text] [Related]
13. Off-label use of biologicals in the management of inflammatory oral mucosal disease.
O'Neill ID
J Oral Pathol Med; 2008 Nov; 37(10):575-81. PubMed ID: 18764859
[TBL] [Abstract][Full Text] [Related]
14. Cyclophosphamide for ocular inflammatory diseases.
Pujari SS; Kempen JH; Newcomb CW; Gangaputra S; Daniel E; Suhler EB; Thorne JE; Jabs DA; Levy-Clarke GA; Nussenblatt RB; Rosenbaum JT; Foster CS
Ophthalmology; 2010 Feb; 117(2):356-65. PubMed ID: 19969366
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine for ocular inflammatory diseases.
Kaçmaz RO; Kempen JH; Newcomb C; Daniel E; Gangaputra S; Nussenblatt RB; Rosenbaum JT; Suhler EB; Thorne JE; Jabs DA; Levy-Clarke GA; Foster CS
Ophthalmology; 2010 Mar; 117(3):576-84. PubMed ID: 20031223
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin therapy for refractory ocular cicatricial pemphigoid: case report.
Galdos M; Etxebarría J
Cornea; 2008 Sep; 27(8):967-9. PubMed ID: 18724167
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenetics of drugs used in the treatment of ocular inflammatory diseases.
Lima BR; Nussenblatt RB; Sen HN
Expert Opin Drug Metab Toxicol; 2013 Jul; 9(7):875-82. PubMed ID: 23521173
[TBL] [Abstract][Full Text] [Related]
18. Rituximab for treatment of ocular inflammatory disease: a series of four cases.
Kurz PA; Suhler EB; Choi D; Rosenbaum JT
Br J Ophthalmol; 2009 Apr; 93(4):546-8. PubMed ID: 19321476
[TBL] [Abstract][Full Text] [Related]
19. Azathioprine for ocular inflammatory diseases.
Pasadhika S; Kempen JH; Newcomb CW; Liesegang TL; Pujari SS; Rosenbaum JT; Thorne JE; Foster CS; Jabs DA; Levy-Clarke GA; Nussenblatt RB; Suhler EB
Am J Ophthalmol; 2009 Oct; 148(4):500-509.e2. PubMed ID: 19570522
[TBL] [Abstract][Full Text] [Related]
20. Long-term progression, prognosis, and treatment of patients with recurrent ocular manifestations of Reiter's syndrome.
Kiss S; Letko E; Qamruddin S; Baltatzis S; Foster CS
Ophthalmology; 2003 Sep; 110(9):1764-9. PubMed ID: 13129875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
